Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Clinical Pharmacy Specialist/CGM Program Coordinator
Department of Endocrinology, Diabetes, and Metabolism
Cleveland Clinic Diabetes Center
Certified Diabetes Educator and Clinical Dietitian
Mountain Vista Medicine
South Jordan, Utah
Associate Director, Scientific Services
This activity is intended for diabetes specialists, primary care clinicians, and other healthcare providers who are part of the diabetes care team including nurses, diabetes care and education specialists, pharmacists, and registered dietitians.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Endocrine Society has achieved Accreditation with Commendation.The Endocrine Society designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Association of Diabetes Care & Education Specialists is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This program provides 0.25 contact hour of continuing education credit.
Provider approved by the California Board of Registered Nursing, Provider # 10977, for 0.25 Contact Hour. RNs must retain this document for 4 years after the activity concludes.
The Association of Diabetes Care & Education Specialists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 0.25 contact hours (0.025 CEU's) of continuing education credit.
ACPE Universal Activity Number: 0069-9999-20-041-H01-P
Effective date: March 31, 2020 to March 31, 2021
This program has been made available online.
Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 31, 2020, through March 30, 2021:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
Short commentary from Dr. Martin Abrahamson on using SGLT2 inhibitors for cardiovascular and renal disease with type 2 diabetes, from CCO
CME commentary: GLP-1 receptor agonists and weight reduction in diabetes. Evidence for exenatide, dulaglutide, liraglutide, semaglutide in T2D and obesity.
From CCO: Susan Schrimpf Davis, DO; Cynthia J. Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD; Deborah A. Milito, PharmD, BCGP, FASCP, discuss the importance of vaccinating older adults against shingles and how to overcome common clinical challenges
Expert recommendations from Clinical Care Options on using oral semaglutide to treat type 2 diabetes